Background: Liver transection is considered a critical factor influencing intra-operative blood loss. A
Introduction
Excessive blood loss during a liver transection and the need for blood transfusions have been shown to be correlated with higher morbidity and mortality rates and with a worse long-term outcome. 1 Hepatic pedicle clamping and maintenance of a low central venous pressure during a liver transection are commonly used procedures in order to minimize the blood loss. 2, 3 The technique of a liver transection is considered another critical factor influencing intra-operative blood loss. Randomized studies comparing the clamp-crushing technique with other techniques [Cavitron ultrasonic surgical aspirator (CUSA), the hydrojet dissector and the radiofrequency dissecting sealer (RFDS)] have shown that the clamp-crushing technique, usually associated with hepatic pedicle clamping, resulted either in similar or lower blood loss and transfusion requirements. [4] [5] [6] Thereafter, the clampcrushing technique associated with bipolar humid coagulation is generally considered to represent the reference standard against which new methods must be compared. 7 Over the years, there has been an increasing extension of the indications for hepatic resection and in the use of pre-operative chemotherapy. The progressive increase in the rate of complex hepatic resections on a liver damaged by pre-operative chemotherapy has determined a growing interest in new devices able to shorten the transection time, to facilitate bloodless transections even without hepatic pedicle clamping and to reduce bile leak. 8 The Ligasure TM Small Jaw Instrument (LF1212) (Covidien, Boulder, CO, USA) is a vessel sealing system that can fuse vessels, up to and including 7 mm, lymphatics and tissue bundles. The LF1212 device has a Kelly shape that allows accurate liver crushing in the standard fashion of the 'classic' clamp-crushing technique. Moreover, some data seem to suggest that this type of vessel sealing system may reduce the risk of bile leakage. 9 The aim of this randomized controlled trial was to identify the most safe and efficient device in terms of overall and 'per cm 2 ' blood loss during a liver transection and in terms of transection time and speed.
Materials and methods
At the Department of Surgical Oncology, Institute for Cancer Research and Treament (IRCC) and at the Hepato-BiliaryPancreatic Surgery and Liver Transplantation Unit, University of Modena and Reggio Emilia, Modena (Italy), from January to December 2012, all patients considered for a curative liver resection were enrolled in this study, after giving written informed consent. A total of 100 consecutive patients whose liver tumours appeared resectable on intra-operative ultrasonography were randomly assigned to undergo a liver transection using kellyclasia plus humid bipolar coagulation (Kelly group: 50 patients) or the Ligasure tm Small Jaw Instrument (Covidien) (LF1212 group: 50 patients) by the surgeon (Fig. 1 ). There were 62 men, and the median (range) age was 64.7 (32.5-84.8) years.
Randomization took place in the operating room after a laparotomy, when the patients were deemed resectable. Patients not eligible for a liver resection after a laparotomy were excluded from the study. Patients were assigned to treatment at the ratio of 1:1 according to a computer-generated randomization list by means of STATA software (version 10 ©; StataCorp LP, College Station, TX, USA). Randomization was restricted by blocking with randomly varying block size and stratified by centre.
Study design
The procedure was approved by the ethical committee of the hospital.
Eligibility criteria included a liver resection either for benign or malignant tumours, 'good hepatic function' defined as ChildPugh class A and a ICG Test ≤15%, an acceptable clotting profile (platelet count 90 × 10 3 ), and adequate cardio-respiratory and renal function. Patients requiring a bile duct resection, vascular resection or undergoing emergency liver surgery were excluded from the study.
Liver transection time and blood loss were calculated from the beginning to the end of the liver resection. The amount of blood loss was measured from the volume of blood in the suction container and from the weight of the soaked gauzes. At the end of liver resection, the area of the transection surface was measured: the transection surface was marked on a piece of transparent plastic sheet and then transcribed to a piece of paper containing marks of square millimeter for the measurement of the area of the liver transection surface.
Assessed for eligibility
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Excluded from analysis n = 0 Analysis Enrolment Allocation Follow-up Figure 1 Study flow chart of a liver resection using Kellyclasia plus humid bipolar coagulation (Kelly group) versus by Ligasure tm Small Jaw
In the Kelly group, transection of the liver parenchyma was performed using a Kelly clamp. Small vessels or bile ducts were mainly controlled by absorbable clips. In the LF1212 group, transection of the liver parenchyma was performed using the Ligasure device; small vessels or bile ducts up to 7 mm were mainly controlled by the Ligasure vessel sealing system.
The application of topical haemostatic agents to the raw surface of the liver at the end of the transection was not allowed unless there was occurrence of persistent bleeding which could not be controlled otherwise. In this case a topical haemostatic matrix (Floseal; Baxter Biosurgery, Deerfield, IL, USA) was used.
A bile duct fistula was defined according to the definition of the International Study Group of Liver Surgery (ISGLS). 10 Bilirubin levels of the drainage liquid were routinely measured on days 3 and 5 after surgery. Liver failure was defined according to the ISGLS definition 11 According to the histological examination of the non-tumoural liver, the parenchyma was defined as normal in the absence of any sign of chemotherapy-induced hepatic injury, chronic liver disease or cirrhosis.
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The primary end-point was to the overall and 'per cm 2 ' blood loss during the liver transection.
Secondary outcomes were transection time, transection speed (calculated as transection area divided by transection time, cm 2 /min), width of the resection margin, transfusion rate and bile leak rate.
Surgical procedure
All operations were performed by two surgeons who were equally skilled in both liver transection techniques. All resections were performed under a central venous pressure (CVP) of 5 cmH2O or less evaluated using a transducer connected to the CVP catheter.
Hepatic pedicle clamping during liver transection was not performed unless the haemorrhage could not otherwise be controlled. In this setting, hepatic pedicle clamping was always intermittent (15 min of clamping and 5 min of release).
Intra-operative ultrasonography was routinely used to guide the transection line.
A major hepatic resection was defined as a resection of three or more contiguous segments.
Statistical analysis
According to previous published data, the sample size calculation was performed with the expectation of a 30-50% difference in overall and 'per cm 2 ' blood loss during a liver resection with a level of statistical significance of 0.05 and a power of 0.80. [4] [5] [6] [7] The accrual target was set at 50 patients for each group.
Results were expressed as median (range). Continuous variables were compared using the most appropriate non-parametric tests test; categorical variables were compared using the χ 2 of Fisher's exact test, as appropriate. The analysis was performed in 'an intention-to-treat' manner. Differences were considered statistically significant at P < 0.050.
All analyses were performed using statistical software (Statistica TM for Windows; StatSoft Italia, Vigonza, Padova, Italy).
Results
Background characteristic
Background characteristics of the two groups are reported in Table 1 . The median number of liver tumours was 2 in the Kelly group compared with 2.9 in the LF1212 group (P = 0.792). Liver metastases from colorectal cancer were the most common indication to hepatic resection: overall, 73% of these patients underwent neoadjuvant chemotherapy, usually oxaliplatin based. A major hepatic resection was an uncommon procedure: most of the patients underwent multiple wedge resections. The liver transection area was larger in the LF1212 group but the difference did not reach statistical significance.
Morbidity and mortality
The in-hospital mortality rate was 3% (n = 3). Two patients died of myocardial ischaemia and liver failure, respectively, 4 and 29 days after a right hepatectomy for colorectal metastases. The last patient died of sepsis and multiorgan failure 70 days after a left hepatectomy for hepatocellular carcinoma associated with cirrhosis. All the patients who died postoperatively were in the LF1212 group (Table 2) .
Thirty-five patients (35%) had post-operative complications. Overall, 15 patients developed a bile duct fistula: type A in 7 patients, type B in 7 patients and type C in 1 patient. According to the ISGLS definition, only one patient developed posthepatectomy liver failure.
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Study outcome Statistical analyses revealed no significant differences between the two groups of the study in terms of overall and 'per cm 2 ' blood loss, transection time, transection speed, transfusion rate, bile leak rate and resection margin width. In particular, the overall and 'per cm 2 ' blood losses were similar in the two groups of the study whereas there was a tendency towards a higher transection speed in the LF1212 group: 0.8 cm 2 /ml versus 1.1 in the Kelly group (P = 0.089).
At final pathological analysis, the median width of the resection margin was 6 mm in both groups of the study. The rate of a positive (0 mm) resection margin was similar in the two groups.
Discussion
Blood loss is one of the most important factors affecting the shortand long-term outcome of patients undergoing a liver resection. 1, 14 Among the 'technical factors' influencing intra-operative blood loss, a liver transection is considered a critical factor. Since the first report of five hepatic resections performed using the clamp-crushing technique, this technique has become the goldstandard form of liver parenchymal transection. 7, 15 However, in the past 10-15 years, a number of surgical devices have been [16] [17] [18] The few published randomized studies have failed to show any significant advantage of one of the new transection methods over the clamp-crushing technique. 15 Lesurtel's trial, which compared four different techniques of liver transection [(clamp-crushing technique versus CUSA versus Hydrojet versus dissecting sealer using radiofrequency energy (Tissuelink, Dover, NH)] showed the superiority of the clampcrushing technique. 5 However the use of hepatic pedicle clamping only in the clamp-crushing cohort may have produced a bias. The LF1212 device is a vessel sealing/divider system which seals vessels up to 7 mm, lymphatics and tissue bundles. The LF1212 forceps allow liver parenchymal transection in a similar manner to the clamp-crushing technique. To our knowledge, the present randomized study is the first one to evaluate the impact of the LF1212 device during liver transection. In the present series, the LF1212 device was demonstrated to be a safe, effective and efficient method for hepatic parenchymal transection even if compared with the 'gold-standard' clamp-crushing technique. In 2009, a randomized study compared the clamp-crushing technique with a vessel sealing system (Ligasure Precise TM ; Valleylab, Boulder, CO, USA) similar to the one used in the present study except for the absence of the cutting knife and the use of an older less efficient energy platform. 19 In both arms of the study, transection of the liver was performed by Kellyclasia: the only difference was the sealing of vessels and ducts smaller than 2 mm by the vessel sealing device in the Ligasure arm whereas vessels and ducts larger than 2 mm were tied and divided. In the present study, the transection of the liver parenchyma in the LF1212 group was performed using the forceps of the vessel sealing device which was used to seal and divide vessels and ducts up to 7 mm.
A drawback of the use of the LF1212 vessel sealing system is the higher cost of each device as compared with the clamp-crushing technique. However, in our practice the use of the LF1212 device has dramatically reduced the need of costly absorbable clips during liver transection.
In the present series, the overall bile leakage rate was 15%, higher than reported in a recent French series but similar to reported by the Makuuchi group. 19, 20 Most of the patients underwent extended and complex wedge resections with a large residual surface area at the end of the liver transection (median transection surface area 50 cm 2 , data not shown). Moreover, half of these patients had type A fistulae which did not require any further treatment. Some concerns have been raised regarding the effectiveness of the vessel sealing system in preventing bile leaks after a liver resection. 21 In the present prospective randomized study, the bile leakage rate was not statistically different between the two groups of the study. Of note, our sample size was not calculated to identify a difference in bile leaks. However, adequate sealing of the intrahepatic bile ducts by the Ligasure vessel sealing system was recently confirmed at the histolgical analyses of the transected liver parenchyma. 9 Moreover, as the lateral thermal spread of the Ligasure device is minimal (1 mm) if compared with, i.e. harmonic scalpel, the LF1212 device can be used close to the hepatic hilum structures or to the hepatic vein confluence. 5 In 2006, a randomized study clearly showed that a liver resection without hepatic pedicle clamping was safe. 2 Since then, we have performed most of the liver resections without using the hepatic pedicle clamping. In the present study, unlike the Lesurtel's study, hepatic pedicle clamping was not allowed in both groups of randomization unless the occurrence of a bleed which could not be controlled otherwise. 5 Overall, about one-third of the patients required hepatic pedicle clamping with a median clamping time of 23 min. The increased rate of hepatic pedicle clamping in the LF1212 group may be explained by a less effective sealing power on the branches of the hepatic veins. In fact, the vessel sealing technology of the LF1212 works by determining the fusion of the connective tissue present in the vessel wall. Thereafter, as the wall of the hepatic veins is thin with less connective tissue than the portal or arterial branches and the vessel sealing may be less effective thus increasing the risk of back-flow bleeding, hepatic pedicle clamping may be used more frequently when working close to the hepatic vein confluence. However, the median clamping time in the LF1212 group was short (15 min). Clamping times shorter than 40 min are associated with minimal cellular injury. 22 The frequent use of neoadjuvant chemotherapy and the tendency to resect multiple, bilateral liver metastases have increased both the risk and the 'need' to have narrow resection margins. However, although a positive resection margin increases the risk of margin recurrence, the tumour biology and not the width of the resection margin affects the long-term outcome. 23, 24 In the present series, only 15% of the patients had a positive resection margin, in spite of the mean number of resected colorectal liver metastases being high (n = 4, data not shown). The technique of liver resection did not impact on the width of the resection margins. The results of the present study compares favourably with those shown by a French study reporting a 24% rate of positive resection margins. 25 The accrual target set at 50 patients for each group was large enough to detect a 30-50% difference in blood loss during liver transection. However, as very few studies have been published that evaluate the vessel-sealing system technique during liver transection, it might be that the reported difference was too high and, thereafter, the '50 patients per-group' target too low to detect significant differences in terms of blood loss.
In conclusion, a liver resection with the Ligasure TM Small Jaw Instrument is associated with similar results in terms of blood loss, transection speed and bile leak rate compared with the conventional clamp-crushing technique. However, the Kelly shape of the Ligasure device which allows accurate and safe liver crushing similar to the 'classic' clamp-crushing technique may increase the surgeon's 'comfort' which is difficult to measure but critically important for the completion of a liver resection.
